MedTrace Logo

Safety and Feasibility of the EyeControl Device

NCT02891629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-08-28

Study results available
· View outcomes & findings →

Summary

The EyeControl device is an eye movement-based communication device in the form of wearable glasses with connected infrared cam-era that tracks the pupil and translates blinks and movements into commands.This study is aimed to demonstrate the safety and feasibility of the EyeControl device in healthy volunteers, and ALS patients in early stages.

Conditions

  • ALS (Amyotrophic Lateral Sclerosis)

Interventions

DEVICE

EyeControl device

Use of device features including control of gestures, use of menus, activation of pre- defined modes and writing full sentences

Sponsors & Collaborators

  • Eyefree Assisting Communication Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-01-28
Completion
2017-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891629 on ClinicalTrials.gov